ICD-10:
198.5's Combination Approach Sees a Change Under ICD-10
Published on Fri Aug 05, 2011
Be sure documentation clearly distinguishes bone from bone marrow metastases.ICD-10 will double your coding options for secondary neoplasms of bone and bone marrow.ICD-9: Under ICD-9 2011, you report 198.5 (Secondary malignant neoplasm of other specified sites; bone and bone marrow) to indicate the confirmed presence of cancer that has spread from a different (primary) site to the bones or bone marrow.ICD-10: The new code set, planned to take effect Oct. 1, 2013, instead may offer two distinct codes: C79.51, Secondary malignant neoplasm of bone C79.52, Secondary malignant neoplasm of bone marrow.Documentation: The switch to two separate codes means that clear confirmation of whether the bone or bone marrow is involved will be crucial to your ability to choose the proper ICD-10 code.Coder tip: Both ICD-9 and ICD-10 provide alternate codes for secondary neuroendocrine tumors. Under ICD- 9, you use 209.73 (Secondary neuroendocrine tumor of bone). ICD-10 includes C7B.03 (Secondary carcinoid [...]